MAB8257
Anti-Influenza A Antibody, nucleoprotein, clone A1
clone A1, Chemicon®, from mouse
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Clone:
A1, monoclonal
Species reactivity:
human
Application:
IF
Citations:
36
biological source
mouse
antibody form
purified immunoglobulin
antibody product type
primary antibodies
clone
A1, monoclonal
species reactivity
human
manufacturer/tradename
Chemicon®
technique(s)
immunofluorescence: suitable
isotype
IgG2a
shipped in
wet ice
Quality Level
Looking for similar products? Visit Product Comparison Guide
Immunogen
Epitope: nucleoprotein
Influenza A
Application
Anti-Influenza A Antibody, nucleoprotein, clone A1 detects level of Influenza A & has been published & validated for use in IF.
Indirect Immunofluorescence of acetone fixed specimens.
Optimal working dilutions must be determined by the end user.
Optimal working dilutions must be determined by the end user.
Research Category
Infectious Diseases
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral
Infectious Diseases - Viral
Biochem/physiol Actions
Specific for the Influenza A nucleoprotein. Has stronger binding with N1-type Flu A. No cross reactivity seen to influenza B or other respiratory viruses. Shown to react with Avian H5N1 strain. No reactivity seen to influenza B or other respiratory viruses.
Physical form
Format: Purified
Protein A Purified mouse immunoglobulin in 20 mM sodium phosphate, 250 mM NaCl, pH. 7.6, with 0.1% sodium azide as a preservative.
Protein A purified
Preparation Note
Maintain for 1 year at 2–8°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Analysis Note
Control
Influenza Control Slides, Catalogue Number 5010-5
Influenza Control Slides, Catalogue Number 5010-5
Other Notes
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Not finding the right product?
Try our Product Selector Tool.
Storage Class
10 - Combustible liquids
wgk
WGK 2
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Evaluation of an epitope-blocking enzyme-linked immunosorbent assay for the detection of antibodies to influenza A virus in domestic and wild avian and mammalian species.
Heather J Sullivan,Bradley J Blitvich,Kaci VanDalen,Kevin T Bentler,Alan B Franklin,J Jeffrey Root
Journal of Virological Methods null
Henry Memczak et al.
PloS one, 11(7), e0159074-e0159074 (2016-07-16)
Antibodies against spike proteins of influenza are used as a tool for characterization of viruses and therapeutic approaches. However, development, production and quality control of antibodies is expensive and time consuming. To circumvent these difficulties, three peptides were derived from
Aftab Alam et al.
Neoplasia (New York, N.Y.), 21(10), 945-962 (2019-08-20)
Down-regulation or loss of MHC class I expression is a major mechanism used by cancer cells to evade immunosurveillance and increase their oncogenic potential. MHC I mediated antigen presentation is a complex regulatory process, controlled by antigen processing machinery (APM)
Evolution of H3N2 influenza virus in a guinea pig model.
Long, J; Bushnell, RV; Tobin, JK; Pan, K; Deem, MW; Nara, PL; Tobin, GJ
Testing null
Liqi Liu et al.
Human vaccines & immunotherapeutics, 14(3), 532-539 (2018-01-05)
Since the first confirmed case of H7N9 infection was reported in China, there have been five epidemic waves of human H7N9 infections between 2013 and 2017. The fifth wave differed from the previous four waves in that highly pathogenic avian
Articles
呼吸道传染病由于其传染性强、传播速度快且发病率高，已成为我国重点防治的一类疾病。目前呼吸道病原体检测方法主要分为血清特异性抗体检测、抗原检测、多重核酸检测以及微生物检测系统。其中，相比于抗体检测，抗原检测在感染病毒初期、出现症状后即可做出检测，适用于疾病的早期诊断，对患者的治疗具有重要指导意义。
Related Content
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service